| Date Filed | Type | Description |
| 01/10/2023 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on ANAPTYSBIO, INC|
Txns:
| Granted 57,260 options to buy
@ $23.23, valued at
$1.3M
Granted 20,980 restricted stock units
@ $0 |
|
| 09/16/2022 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on ANAPTYSBIO, INC|
Txns:
| Granted 12,000 restricted stock units
@ $0 |
|
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on ANAPTYSBIO, INC|
Txns:
| Granted 70,000 options to buy
@ $30.44, valued at
$2.1M
|
|
| 11/17/2021 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on ANAPTYSBIO, INC|
Txns:
| Granted 964 shares
@ $22.03, valued at
$21.2k
|
|
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2020 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on ANAPTYSBIO, INC|
Txns:
| Granted 90,600 options to buy
@ $20.16, valued at
$1.8M
|
|
| 07/15/2020 |
3
| MULROY DENNIS (CFO) has filed a Form 3 on ANAPTYSBIO, INC |
| 06/02/2020 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 82 shares
@ $4.01, valued at
$328.8
Granted 82 options to buy
@ $4.72, valued at
$387 |
|
| 05/19/2020 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 56 shares
@ $5.86, valued at
$328.2
Granted 56 options to buy
@ $6.89, valued at
$385.8 |
|
| 05/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2020 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 58 shares
@ $5.61, valued at
$325.4
Granted 58 options to buy
@ $6.6, valued at
$382.8 |
|
| 01/13/2020 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 30,000 options to buy
@ $5.25, valued at
$157.5k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2019 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 112 shares
@ $2.85, valued at
$319.2
Granted 112 options to buy
@ $3.35, valued at
$375.2 |
|
| 12/03/2019 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 138 shares
@ $2.33, valued at
$321.5
Granted 138 options to buy
@ $2.74, valued at
$378.1 |
|
| 11/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/05/2019 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 267 shares
@ $5.96, valued at
$1.6k
Granted 267 options to buy
@ $7.02, valued at
$1.9k
|
|
| 10/17/2019 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 224 shares
@ $7.12, valued at
$1.6k
Granted 224 options to buy
@ $8.38, valued at
$1.9k
|
|
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2019 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 196 shares
@ $8.13, valued at
$1.6k
Granted 196 options to buy
@ $9.57, valued at
$1.9k
|
|
| 08/16/2019 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 198 shares
@ $8.02, valued at
$1.6k
Granted 198 options to buy
@ $9.43, valued at
$1.9k
|
|
| 08/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2019 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 203 shares
@ $7.85, valued at
$1.6k
Granted 203 options to buy
@ $9.24, valued at
$1.9k
|
|
| 07/01/2019 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 202 shares
@ $7.86, valued at
$1.6k
Granted 202 options to buy
@ $9.25, valued at
$1.9k
|
|
| 06/18/2019 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 193 shares
@ $8.25, valued at
$1.6k
Granted 193 options to buy
@ $9.71, valued at
$1.9k
|
|
| 06/03/2019 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 347 shares
@ $4.58, valued at
$1.6k
Granted 347 options to buy
@ $5.39, valued at
$1.9k
|
|
| 05/17/2019 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 285 shares
@ $5.58, valued at
$1.6k
Granted 285 options to buy
@ $6.57, valued at
$1.9k
|
|
| 05/02/2019 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 233 shares
@ $6.84, valued at
$1.6k
Granted 233 options to buy
@ $8.05, valued at
$1.9k
|
|
| 04/17/2019 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 261 shares
@ $6.09, valued at
$1.6k
Granted 261 options to buy
@ $7.16, valued at
$1.9k
|
|
| 04/02/2019 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 59 shares
@ $5.47, valued at
$322.7
Granted 59 options to buy
@ $6.43, valued at
$379.4 |
|
| 03/19/2019 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 49 shares
@ $6.49, valued at
$318
Granted 49 options to buy
@ $7.64, valued at
$374.4 |
|
| 03/04/2019 |
4
| MULROY DENNIS (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 65 shares
@ $4.85, valued at
$315.3
Granted 65 options to buy
@ $5.7, valued at
$370.5 |
|
|